Coronary disease & ACSCohort study
Disparities in achieving low-density lipoprotein cholesterol goals after revascularization in a diverse real-world cohort
- Retrospective cohort study
- single health system
Authors' conclusion
Among patients with ASCVD who underwent revascularization, a large proportion did not have follow-up LDL-C testing, and in those who did, testing was delayed. Only half of patients achieved LDL-C levels below 70 mg/dL (1.8 mmol/L), with female and non-Hispanic Black patients less likely to attain this goal.
Study context
- Population
- Patients with atherosclerotic cardiovascular disease (ASCVD) after percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) or peripheral artery disease (PAD) revascularization, 2018–2023, New York City health system
- Participants
- 6,405 patients
- Exposure
- Female vs Non-Hispanic Black
- Outcome
- Follow-up LDL-C testing and LLT utilization
Main finding
As reported in the abstract
Follow-up low-density lipoprotein cholesterol (LDL-C) test
4319 (67%)
Median time to follow-up LDL-C testing (months)
11
Follow-up testing within 6 months
35%
LDL-C < 70 mg/dL (1.8 mmol/L) at follow-up
2259 (52%)
Observational data: associations, not effects.
Further findings
Achieving follow-up LDL-C < 70 mg/dL (1.8 mmol/L), multivariable adjusted
| Comparison | OR (95% CI) | |
|---|---|---|
| Female · female sex · lower likelihood, after multivariable adjustment | 0.70 (0.61–0.80) | |
| Non-Hispanic Black · non-Hispanic Black race/ethnicity · lower likelihood, after multivariable adjustment | 0.57 (0.49–0.67) | |
| 0.512Odds ratio (log scale) |
Original publication
Summarised from the published abstract; every number is checked against it